Medication reference
Aztreonam-avibactam
Monograph awaiting updateThis monograph will be updated in the future.
No original site article was mapped to this record. The available historical structured fields and official-source links are retained.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- aztreonam-avibactam
Source ID
H51-A5A01B76C6D9AB1DB1C145AB - Generic name
- Aztreonam-avibactam
Source ID
H51-91BA4C704E7F2E2D638E0A86 - Class
- Antibacterial
Source ID
H51-32F3B671D5650E9B2DEFE71A - Subclass
- Monobactam plus beta-lactamase inhibitor
Source ID
H51-2E06C58EA372AEC9A36526AD - Primary uses
- Complicated intra-abdominal infection in adults with limited or no alternative options, used with metronidazole
Source ID
H51-DF1EA00DAD62BDEDF49CB2E3
- Complicated intra-abdominal infection in adults with limited or no alternative options, used with metronidazole
- Mechanism
- The beta-lactam component inhibits penicillin-binding proteins and cell-wall synthesis; its partner protects or enhances activity against selected resistance mechanisms.
Source ID
H51-8FD20D26D30DB28D9A66FF3F - Mechanism level
- class_level
Source ID
H51-9A31ECB8CB5C33699965C6D5 - Basic dosing orientation
- Adult loading dose, CLcr greater than 50 mL/min | Existing preparation record; use current package insert for indication-specific selection | 2.67 g total (2 g aztreonam/0.67 g avibactam) | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult maintenance, CLcr greater than 50 mL/min | Existing preparation record; use current package insert for indication-specific selection | 2 g total (1.5 g aztreonam/0.5 g avibactam) every 6 hours | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion
Source ID
H51-23D5BCC3224D0DD731BA5BB6 - Administration orientation
- Infuse over 3 hours
Source ID
H51-230E2ACD75EAF7EDFA60FED8 - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method.
Source ID
H51-5BF7244B7FF95BA415C0BECD - Key safety orientation
- Serious beta-lactam hypersensitivity can occur.
Source ID
H51-48AE9DA8D108BBD72BFEA727 - Renal function may change during therapy and changes both dose and interval.
Source ID
H51-908E7E87694D4E9462140587 - Do not mix with other drugs in the same solution.
Source ID
H51-397FC552BB53070847E2915D
- Serious beta-lactam hypersensitivity can occur.
- Coverage path
- structured_local_snapshot
Source ID
H51-D681336243C5F5A275752B76 - Coverage path label
- Structured GlobalRPh route snapshot
Source ID
H51-22FD6D8F86D820EE5872571D - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be1a6c99-d4b3-46d7-9e99-6e5f9fab556a (opens in a new tab)
Source ID
H51-4CFD828A6E1C307762A8EB7A - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-75E6FB5D8B7B505CB9F386C2 - Search text
- Aztreonam-avibactam Antibacterial Monobactam plus beta-lactamase inhibitor Complicated intra-abdominal infection in adults with limited or no alternative options, used with metronidazole The beta-lactam component inhibits penicillin-binding proteins and cell-wall synthesis; its partner protects or enhances activity against selected resistance mechanisms. Adult loading dose, CLcr greater than 50 mL/min | Existing preparation record; use current package insert for indication-specific selection | 2.67 g total (2 g aztreonam/0.67 g avibactam) | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult maintenance, CLcr greater than 50 mL/min | Existing preparation record; use current package insert for indication-specific selection | 2 g total (1.5 g aztreonam/0.5 g avibactam) every 6 hours | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion Infuse over 3 hours Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method. Serious beta-lactam hypersensitivity can occur. Renal function may change during therapy and changes both dose and interval. Do not mix with other drugs in the same solution. Structured GlobalRPh route snapshot
Source ID
H51-23F831DEC92B7F5FDA3B9280 - Official access mode
- direct_label
Source ID
H51-F14024DD4F7F8CDA9A0D73B2 - Official access url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be1a6c99-d4b3-46d7-9e99-6e5f9fab556a (opens in a new tab)
Source ID
H51-1151DAF92398782E5F5CB929 - Official access reason
- A source-specific DailyMed label route is available.
Source ID
H51-D23643CC0F870838D6EF83BD - Label snapshot available
- true
Source ID
H51-03B9EE4C9B46A0B167F7323A - Label snapshot setid
- be1a6c99-d4b3-46d7-9e99-6e5f9fab556a
Source ID
H51-B53A1E200C4CB593405267F5
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- A retrieved source document is available; clinical reconciliation and a second-source claim map remain incomplete
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- adjustment_required
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- class_level
- Provenance classification
- historical_class_level
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Source kind
- label_snapshot
- Local pointer
- /mechanism_summary
- Original level
- class_level
- Provenance classification
- historical_class_level
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Concise GlobalRPh summary reviewed against the selected DailyMed label clinical-pharmacology or microbiology content.
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
No separate structured rows were bundled for IV push, continuous infusion, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical dilution and intermittent infusion preparation
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)| Population | Amount | Reconstitution | Diluent | Final volume | Concentration | Rate | Stability | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-6FF813B8FA5DE1B91A2F2B03Source IDH51-9F36CACDEA2763BBBE0FF652 | 2.67 g total (2 g aztreonam/0.67 g avibactam)Source IDH51-177B64E7BB873F3B3145409E | Reconstitute each vial with 10 mL Sterile Water for Injection; approximately 12 mL final per vial.Source IDH51-86B01107B9F1D3050AA62E9C | NS, D5W, or LRSource IDH51-A0A273B5BC09BDFA0C4EFBB3 | Dilute withdrawn volume to 50 to 250 mLSource IDH51-0500BCE871176AD78D5C1B90 | Aztreonam 2.7 to 40 mg/mL and avibactam 0.9 to 13.3 mg/mLSource IDH51-224223C0AC08C6BC2571F65E | Infuse over 3 hoursSource IDH51-6B948FD9AA241498C3206112 | Reconstituted vial: up to 60 minutes at not more than 30 C. NS or LR bag: up to 24 hours refrigerated then 12 hours at not more than 30 C. D5W bag: up to 24 hours refrigerated then 4 hours at not more than 30 C.Source IDH51-7DA62158202717B775E72D64 | Loading dose requires two vials.Source IDH51-49FCBED13B0605A5F24AC185 |
Source IDH51-81B1AC9E8A587CC74360095CSource IDH51-C56D39AA85B6B4D63C7BFD5F | 2 g total (1.5 g aztreonam/0.5 g avibactam) every 6 hoursSource IDH51-741F5413343A744D7F26256B | Reconstitute one vial with 10 mL Sterile Water for Injection.Source IDH51-616CE3609A1DE390D484FBAC | NS, D5W, or LRSource IDH51-B0A162409D1C3E40AD048C33 | 50 to 250 mLSource IDH51-64A9AC7F2D0543856DF8E7F1 | Within label rangeSource IDH51-C2307B2A75240EBA8A16D17F | Infuse over 3 hoursSource IDH51-DF18DFB0D53FAB3EC33A9E3E | Use label-specific limits above and apply the shorter USP sterility-based ceiling.Source IDH51-FE3E3B16C61385B9ADEDC350 | Renal adjustment is required at CLcr 50 mL/min or less.Source IDH51-4933981EFD447F4503709850 |
Historical DailyMed label snapshot
Recovered v5.1 source content; historical, awaiting current review.
- Id
- aztreonam-avibactam
Source ID
H51-92DF6BFF9D3B1851892D59E7 - Catalog name
- Aztreonam-avibactam
Source ID
H51-3D9A156AF433F7B5AB6175DA - Selection status
- accepted_high_confidence
Source ID
H51-4C806F0657B3CD885EB404CB - Confidence
- very_high
Source ID
H51-88DFAE9ED170616D58E79345 - Match path
- verified_direct_label
Source ID
H51-1BEC7ACE88CE276E51B81CDA - Brand name
- EMBLAVEO
Source ID
H51-19C132FE7213289CE6D5AA46 - Label title
- EMBLAVEO (aztreonam and avibactam) powder for solution
Source ID
H51-9649E08C488A55E334D22326 - Setid
- be1a6c99-d4b3-46d7-9e99-6e5f9fab556a
Source ID
H51-577045A03D4516F698F9EA55 - Route
- Loading dose followed by extended intravenous infusions
Source ID
H51-055401EDED5B5DBA203BE5AC - Dosage form
- Combination powder for reconstitution and further dilution
Source ID
H51-A1B600E36381088FCB2EFE6F - Dosage administration summary
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)
- Use the current indication- and renal-function-specific table. In adults with high renal function, the label uses a loading dose followed by maintenance doses infused over 3 hours.
Source ID
H51-B006A4E4EE67E27DE526FBC9 - Reconstitute the vial with the labeled volume and further dilute the calculated dose in a compatible 50 to 250 mL infusion container.
Source ID
H51-F31EEC8BA0336DDF90934A17 - Renal function changes both dose and interval; reassess frequently when renal function is changing.
Source ID
H51-DB6060CF7D4D90BAE3EC86AB
- Use the current indication- and renal-function-specific table. In adults with high renal function, the label uses a loading dose followed by maintenance doses infused over 3 hours.
- Dosage forms strengths
- 2 g single-dose vial containing 1.5 g aztreonam and 0.5 g avibactam
Source ID
H51-63B633075FB00D87B0634D52
- 2 g single-dose vial containing 1.5 g aztreonam and 0.5 g avibactam
- Mechanism summary
- Aztreonam inhibits bacterial penicillin-binding proteins; avibactam inhibits selected beta-lactamases and protects aztreonam from hydrolysis.
Source ID
H51-7459A4B1F5499F4874171C83 - Scope note
- Selected EMBLAVEO combination label. Do not apply to aztreonam alone.
Source ID
H51-98DD676F8C95E1F2087F47CF - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be1a6c99-d4b3-46d7-9e99-6e5f9fab556a (opens in a new tab)
Source ID
H51-51874F9BC9C2752BBC1AFC25 - Reviewed on
- 2026-08-31
Source ID
H51-7D59700845DFD4B6D22C1886 - Mechanism source
- Concise GlobalRPh summary reviewed against the selected DailyMed label clinical-pharmacology or microbiology content.
Source ID
H51-214A4A458BAB8C269DBE18A2 - Source sections
- Dosage and Administration
Source ID
H51-169EA391AC12A06DE84FFC6C - Dosage Forms and Strengths
Source ID
H51-84FA63A3AE3F38A138932C81 - Clinical Pharmacology or Microbiology as applicable
Source ID
H51-ED1EC425C7CB11818D31CAD6
- Dosage and Administration
- Retrieval method
- Manual build-time review of the current DailyMed full prescribing information for the selected Set ID; no live server retrieval is required during page use.
Source ID
H51-B435C64ECED02E8A56050BBE - Label status
- current
Source ID
H51-00AE73A9ED9DC3C7974CDD5B - Disclaimer
- Verify the exact formulation, strength, manufacturer, NDC, route, current label revision, patient-specific order, institutional policy, and monitoring before use.
Source ID
H51-94014A4DA36300744EBE55C3
Historical indication and population dosing
Recovered tables and source-separated snapshots; full clinical revalidation remains pending.
Existing dose and route snapshots
Separate renal reference: Open Renal Dosing Master (opens in a new tab)| Route | Population | Indication | Dose | Interval | Duration | Administration | Source level | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-E4FE6BCC1B649F1210F7D895Source IDH51-4A358937FAB394CC1B6459BC | Adult loading dose, CLcr greater than 50 mL/minSource IDH51-48385FB0B09AC369612DE979 | Existing preparation record; use current package insert for indication-specific selectionSource IDH51-648E67BE393858C983B7761E | 2.67 g total (2 g aztreonam/0.67 g avibactam)Source IDH51-5431DE31292388B034F76E14 | Not normalized in the preparation recordSource IDH51-CDA7060E4A739B6AD8A794FD | See current package insert and professional guidanceSource IDH51-B48DB1F2F29FC57D640ABC28 | Infuse over 3 hoursSource IDH51-38643E267A1D93AEBF609FA5 | Existing GlobalRPh structured preparation snapshotSource IDH51-A0CCEF6F7BE5889FADC3AC98 | Loading dose requires two vials.Source IDH51-84F7DCB3FD7DCDBAD3FAABB7 |
Source IDH51-EA477F57B23E5DF9E81D87ECSource IDH51-1D435928143AA3BCC5370CB8 | Adult maintenance, CLcr greater than 50 mL/minSource IDH51-2A8A4AB53970F2AE830F790F | Existing preparation record; use current package insert for indication-specific selectionSource IDH51-42BD3628B4B9882415F5C80F | 2 g total (1.5 g aztreonam/0.5 g avibactam) every 6 hoursSource IDH51-83B8621FC69CEEE045CDE5E5 | Not normalized in the preparation recordSource IDH51-06AD6F2E8E202482789D2624 | See current package insert and professional guidanceSource IDH51-A62F2A9D0CB9F55195F33C4A | Infuse over 3 hoursSource IDH51-FE69DA9227DB880BC4DD3CE9 | Existing GlobalRPh structured preparation snapshotSource IDH51-BACA9245ADA283B4364EE538 | Renal adjustment is required at CLcr 50 mL/min or less.Source IDH51-A009D1B5C6167282DDAC46F3 |
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- adjustment_required
Source ID
H51-5B45761FF81BADBA0E6768AD - Summary
- Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method.
Source ID
H51-101E8067CF14CB16EEAC29DD - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-68183DA12EDFB436EEE1BD0E
Historical Common IV uses
Recovered v5.1 source content; historical, awaiting current review.
- Complicated intra-abdominal infection in adults with limited or no alternative options, used with metronidazole
Source ID
H51-360A35D1D40EA6C7D66D0516
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Serious beta-lactam hypersensitivity can occur.
Source ID
H51-6D618196D8F8BDD12928BE3C - Renal function may change during therapy and changes both dose and interval.
Source ID
H51-F9C160DFC55A0752379801C8 - Do not mix with other drugs in the same solution.
Source ID
H51-175907033D0DA823E7D38BCA
Historical Monitoring
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal function
Source ID
H51-9D08958FE6976CE64E4EB58C - Hepatic tests
Source ID
H51-E4FED64C80211BBEF67CCE69 - Clinical and microbiologic response
Source ID
H51-212644BE82690970ED81B7A9
Historical supplemental professional sources
Recovered v5.1 source content; historical, awaiting current review.
| Label | Url | Kind |
|---|---|---|
Source IDH51-F18AB587EBF9A0A7B6B877FCSource IDH51-97F4F7C000A1C5B49934BA32 | https://idmp.ucsf.edu/adult-antimicrobial-dosing-non-dialysis (opens in a new tab)Source IDH51-89554F5190284F37FA307A3C | Professional institutional guidanceSource IDH51-483686669521775532CBD223 |
Source IDH51-ECC625F5C52FC66825785F7BSource IDH51-215A975FABE8A5804029BA7C | https://idmp.ucsf.edu/antimicrobial-dosing-intermittent-continuous-hemodialysis (opens in a new tab)Source IDH51-7BB3BD370CC12FCDF6E9A5B6 | Professional institutional guidanceSource IDH51-BDE405F25E19BB2DA5049F04 |
Source IDH51-6EBA7DEA1A8ABDD97E368EA6Source IDH51-ADDF409C5E4E1B714583E004 | https://idmp.ucsf.edu/pediatric-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)Source IDH51-7B7590B227E5C242026660AE | Professional institutional guidanceSource IDH51-B4DC3B4B3ECDD7D22E8D9A43 |
Source IDH51-B26800CE76E9DCEE5D452D1DSource IDH51-E0392A75B2E1BA5F83AED7EC | https://idmp.ucsf.edu/neonatal-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)Source IDH51-BFD0A8D7B7A5A272E0DB355C | Professional institutional guidanceSource IDH51-E711866553C267FE26F9429B |
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
aztreonam-avibactamSource ID
H51-938AF00A20DBFAED21A34863Generic name
Aztreonam-avibactamSource ID
H51-FF62CB7DFC42CCB0336705B7Brand names
- Emblaveo
Source ID
H51-6A6DE84988E1E23FA1B109FC
Aliases
- aztreonam avibactam
Source ID
H51-0EAFFDD56A1DB2AAC5D1A77B
Class
AntibacterialSource ID
H51-EE700F4CB949488F345F7907Subclass
Monobactam plus beta-lactamase inhibitorSource ID
H51-547C5FFC3009EED3B7ABA73FSummary
Newer fixed 3:1 combination supplied as 1.5 g aztreonam plus 0.5 g avibactam per vial, with a loading dose followed by prolonged maintenance infusions.Source ID
H51-F3ED5EA126C97CD423F257E7Populations
- Adult
Source ID
H51-50C089A9CF3C139D4678827C
Evidence tier
Current-label candidate - verify exact productSource ID
H51-F12B6FF5615F9F72A71697ABHigh alert
falseSource ID
H51-29C9F9580935E08366E11146Hazardous
falseSource ID
H51-2BB019F31D0ECD4582131F30Status
ActiveSource ID
H51-F7B42EDED6D4F454F4502A8AReviewed
2026-08-29Source ID
H51-516788AA09AE8DD29C7D0F24Version added
1.2Source ID
H51-6E61FC2C6D3A3807E3261192Sources
| Label | Url | Kind |
|---|---|---|
Source IDH51-E390D847607A5857B606E024Source IDH51-7A18326CC37DC2844A0B4B07 | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be1a6c99-d4b3-46d7-9e99-6e5f9fab556a (opens in a new tab)Source IDH51-774973EADD31B45C4F4E85A1 | PrimarySource IDH51-D97696143882A5FA760680A2 |
Source IDH51-9EA5813F9E0238FE3435CE52Source IDH51-6074F9C3E041D91C9F7ADF95 | legacy:autoSource IDH51-B9068BD615C754EE7018ACFF | LegacySource IDH51-D8FFC5D5A93DAF6123D699F7 |
Clinical release verification
- Audit version
- 3.4
Source ID
H51-4A2D44AC6C87FCB0C43E8732 - Audited on
- 2026-08-30
Source ID
H51-FFAD45EFB8E7638656DDF19D - Level
- amber
Source ID
H51-F3EE38C54B4E0DFACF9B4D36 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-DE9AADA8B7DF89226CA1F430 - Exact current label candidate
- false
Source ID
H51-94A9DCC821708518746EAF35 - Selected setid
- be1a6c99-d4b3-46d7-9e99-6e5f9fab556a
Source ID
H51-5EDEE74702FE2DF0DD06BF8C - Numeric support ratio
- 0
Source ID
H51-571C76EBB33B28571CDD667B - Reference url count
- 5
Source ID
H51-0D32C1CC677634EFB295365E - Broken reference count
- 0
Source ID
H51-07F312CCEC1A4BAC229AE5C2 - Point of use confirmation required
- true
Source ID
H51-13AC7F70D051A7F835AD6D17 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-E4374D159155B8E87876A322 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Aztreonam-avibactam (opens in a new tab)
Source ID
H51-99A656C751CDF5E35C6B8CC8
Dosing source fields
Id
aztreonam-avibactamSource ID
H51-B63AF989A332E2D57A40D61FGeneric name
Aztreonam-avibactamSource ID
H51-86CCCA8BD094C9C4D2B3F7EECoverage status
direct_official_label_access_plus_local_snapshotSource ID
H51-5DF5E1AF02B533108EF9A589Package insert
- Query name
- Aztreonam-avibactam
Source ID
H51-403041655876783D932A4131 - Preferred setid
- be1a6c99-d4b3-46d7-9e99-6e5f9fab556a
Source ID
H51-8F650CF0316079746B7B48E4 - Product and route must match
- true
Source ID
H51-53FAE84B322460614D39093E - Live current label enabled
- false
Source ID
H51-1E4E51ADE2C3798CF72C578C - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-FB91303C4828F34C9795C948 - Direct official label access enabled
- true
Source ID
H51-3B2C8B3CDB81E37F8CBECAF2 - Outbound server request required
- false
Source ID
H51-B6A106F141570BAF7ECFC9F0 - Local summary status
- not_bundled
Source ID
H51-2C856525FBC7BF5785FB9EE4
Clinical review
- Locally normalized
- false
Source ID
H51-45C7E90FFA7DEAA87D18F1C0 - Reviewed
- 2026-08-29
Source ID
H51-86BA40EF81AD390F49571275 - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-5BA1BA02D354789CF3469B85
Clinical release verification
- Audit version
- 3.4
Source ID
H51-51E07DA5D1B2F771A089EDA3 - Audited on
- 2026-08-30
Source ID
H51-DC045BC6D2B17DA7818B9AFA - Level
- amber
Source ID
H51-CA77BFA6168E048C918984B5 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-1EB5BFEDEAE0FA3D09E5AD77 - Exact current label candidate
- false
Source ID
H51-C36644D0553C0C4FEBAFF797 - Selected setid
- be1a6c99-d4b3-46d7-9e99-6e5f9fab556a
Source ID
H51-6E45BEDF98B64205C17585DF - Numeric support ratio
- 0
Source ID
H51-36F015F073D3147EEA2F4B2D - Reference url count
- 5
Source ID
H51-9339434522490A28FE5C438F - Broken reference count
- 0
Source ID
H51-02F777E3DFF89942E3D8E2DF - Point of use confirmation required
- true
Source ID
H51-6E450DE9B6EE9CFBDC59E71C - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-C96F9956D5BBCDB64A5093AD - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Aztreonam-avibactam (opens in a new tab)
Source ID
H51-D12F3EDAF47CBE79D2ADDDD8
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- aztreonam-avibactam
Source ID
H51-DA6B6D49ACF3A53AFEB4C07F - Name
- Aztreonam-avibactam
Source ID
H51-29059C8850426CE5C71D223C - Brands
- Emblaveo
Source ID
H51-2364EE1777C9D4B3D073370B - Therapeutic class
- Antibacterial
Source ID
H51-D806F1896C6BDE6FC906D4DC - Review version
- 3.1
Source ID
H51-82E5C493CAB51F32F0120322 - Review date
- 2026-08-30
Source ID
H51-F0C0BDD079D88AE4A8788CA1 - Release status
- structured_record_current_label_not_confirmed
Source ID
H51-195C978414E01D5025334D12 - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-15CAEA345C46768BD89BC03C - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-8D4BAE73DC380B9607A390EB
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-48BC0ACA5B37726E23081432 - Reconstitution concentration
- Reconstitute each vial with 10 mL Sterile Water for Injection; approximately 12 mL final per vial. Reconstitute one vial with 10 mL Sterile Water for Injection.
Source ID
H51-8E3831FA3FF3B32D5AB5D41D - Maximum or recommended final concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-6BC6ACBBACF285BD0FE8C127 - Appropriate standardized containers
- Dilute withdrawn volume to 50 to 250 mL 50 to 250 mL
Source ID
H51-4974148E7AC6F7AD6000DD7A - Adult dosing range
- 2.67 g total (2 g aztreonam/0.67 g avibactam) 2 g total (1.5 g aztreonam/0.5 g avibactam) every 6 hours
Source ID
H51-3EC996A273B4053F34795CA7 - Pediatric dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-08EE8A45C6DDCD888FA125AB - Neonatal dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-1974D02F6987DA83504D0081 - Infusion time
- Infuse over 3 hours
Source ID
H51-4A55BC0CCF1E16E45655C175 - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-1F67E799A779F269D5806B12 - Current manufacturer labeling
- Setid
- be1a6c99-d4b3-46d7-9e99-6e5f9fab556a
Source ID
H51-751ABA453954D76C0D80713C - Match confidence
- unresolved
Source ID
H51-81AA99104FAA9D56C23C89B1 - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Aztreonam-avibactam (opens in a new tab)
Source ID
H51-915C2C377C9EB3A6ECC621BC
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-CED7E69D02780598769CC189
- Reconstitution concentration
- Primary
- existing_structured_record
Source ID
H51-0AC4B622FE14DCAAB7419924
- Maximum or recommended final concentration
- Primary
- not_found
Source ID
H51-F06DE5159B46A03A9FB9BEEA
- Appropriate standardized containers
- Primary
- existing_structured_record
Source ID
H51-DB0E037E8FF966716FAB44A4
- Adult dosing range
- Primary
- existing_structured_record
Source ID
H51-7BB16751FF1180AB059C0D1A
- Pediatric dosing range
- Primary
- not_found
Source ID
H51-A058A11DC4B1C4D64C041D6E
- Neonatal dosing range
- Primary
- not_found
Source ID
H51-35FD67E3EDF1CAD3156D3EB1
- Infusion time
- Primary
- existing_structured_record
Source ID
H51-F0343470C87CE484367B0DD4
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-6B642D510D3021CA20A29A79
- Current manufacturer labeling
- Primary
- DailyMed current-label gateway
Source ID
H51-B8278620FD238614E2CFF71B
- Population applicability
- Adult
- Applicability
- supported_or_source_present
Source ID
H51-3BFB82D1F2AFDD341C6F0DDA - Guide generation allowed
- true
Source ID
H51-8EA8A7676CBB35AB34336856
- Pediatric
- Applicability
- supported_or_source_present
Source ID
H51-01E08233A526D4520EC4C377 - Guide generation allowed
- false
Source ID
H51-93E24CCA3751E62A6E954A30
- Neonatal
- Applicability
- supported_or_source_present
Source ID
H51-C76F2D0FB74AF05A0C8FC6C8 - Guide generation allowed
- false
Source ID
H51-5D412E91E605E8581DCFF36A
- Route presence
- Structured dilution
- true
Source ID
H51-9F283B05AE30598B453B4A75 - Iv push
- false
Source ID
H51-E49A5EF7593841698DE38128 - Continuous infusion
- false
Source ID
H51-8892B22256F155C9CBD73917 - Pediatric source
- true
Source ID
H51-657EB1F29D912CADD89916BB - Neonatal source
- true
Source ID
H51-81DAEB99F6A5E5D17A5EC1AA
- Legacy reference
- Status
- not_available
Source ID
H51-668B28DF690090F4099B3A9B
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-A3760A7A9DB5FB90DB3F774E - Existing setids
- be1a6c99-d4b3-46d7-9e99-6e5f9fab556a
Source ID
H51-17597A3AE0C8A4DE78A898D2
- be1a6c99-d4b3-46d7-9e99-6e5f9fab556a
- Source files
- catalog.json
Source ID
H51-3F21567D1A964BCD744E6631 - dosing.json
Source ID
H51-C9D7E8EFAD7F140BBADD8082 - new-in-v1.2.json
Source ID
H51-CAE4CF033DBCEF10E6F2E69F
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-9BA7C7CF8590FB55164A90B1
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-938AF00A20DBFAED21A34863 | catalog.json/records/31/id | Historical; current review incomplete |
H51-FF62CB7DFC42CCB0336705B7 | catalog.json/records/31/generic_name | Historical; current review incomplete |
H51-6A6DE84988E1E23FA1B109FC | catalog.json/records/31/brand_names/0 | Historical; current review incomplete |
H51-0EAFFDD56A1DB2AAC5D1A77B | catalog.json/records/31/aliases/0 | Historical; current review incomplete |
H51-EE700F4CB949488F345F7907 | catalog.json/records/31/class | Historical; current review incomplete |
H51-547C5FFC3009EED3B7ABA73F | catalog.json/records/31/subclass | Historical; current review incomplete |
H51-F3ED5EA126C97CD423F257E7 | catalog.json/records/31/summary | Historical; current review incomplete |
H51-360A35D1D40EA6C7D66D0516 | catalog.json/records/31/common_uses/0 | Historical; current review incomplete |
H51-6FF813B8FA5DE1B91A2F2B03 | catalog.json/records/31/preparations/0 | Historical; current review incomplete |
H51-9F36CACDEA2763BBBE0FF652 | catalog.json/records/31/preparations/0/population | Historical; current review incomplete |
H51-177B64E7BB873F3B3145409E | catalog.json/records/31/preparations/0/amount | Historical; current review incomplete |
H51-86B01107B9F1D3050AA62E9C | catalog.json/records/31/preparations/0/reconstitution | Historical; current review incomplete |
H51-A0A273B5BC09BDFA0C4EFBB3 | catalog.json/records/31/preparations/0/diluent | Historical; current review incomplete |
H51-0500BCE871176AD78D5C1B90 | catalog.json/records/31/preparations/0/final_volume | Historical; current review incomplete |
H51-224223C0AC08C6BC2571F65E | catalog.json/records/31/preparations/0/concentration | Historical; current review incomplete |
H51-6B948FD9AA241498C3206112 | catalog.json/records/31/preparations/0/rate | Historical; current review incomplete |
H51-7DA62158202717B775E72D64 | catalog.json/records/31/preparations/0/stability | Historical; current review incomplete |
H51-49FCBED13B0605A5F24AC185 | catalog.json/records/31/preparations/0/notes | Historical; current review incomplete |
H51-81B1AC9E8A587CC74360095C | catalog.json/records/31/preparations/1 | Historical; current review incomplete |
H51-C56D39AA85B6B4D63C7BFD5F | catalog.json/records/31/preparations/1/population | Historical; current review incomplete |
H51-741F5413343A744D7F26256B | catalog.json/records/31/preparations/1/amount | Historical; current review incomplete |
H51-616CE3609A1DE390D484FBAC | catalog.json/records/31/preparations/1/reconstitution | Historical; current review incomplete |
H51-B0A162409D1C3E40AD048C33 | catalog.json/records/31/preparations/1/diluent | Historical; current review incomplete |
H51-64A9AC7F2D0543856DF8E7F1 | catalog.json/records/31/preparations/1/final_volume | Historical; current review incomplete |
H51-C2307B2A75240EBA8A16D17F | catalog.json/records/31/preparations/1/concentration | Historical; current review incomplete |
H51-DF18DFB0D53FAB3EC33A9E3E | catalog.json/records/31/preparations/1/rate | Historical; current review incomplete |
H51-FE3E3B16C61385B9ADEDC350 | catalog.json/records/31/preparations/1/stability | Historical; current review incomplete |
H51-4933981EFD447F4503709850 | catalog.json/records/31/preparations/1/notes | Historical; current review incomplete |
H51-6D618196D8F8BDD12928BE3C | catalog.json/records/31/warnings/0 | Historical; current review incomplete |
H51-F9C160DFC55A0752379801C8 | catalog.json/records/31/warnings/1 | Historical; current review incomplete |
H51-175907033D0DA823E7D38BCA | catalog.json/records/31/warnings/2 | Historical; current review incomplete |
H51-9D08958FE6976CE64E4EB58C | catalog.json/records/31/monitoring/0 | Historical; current review incomplete |
H51-E4FED64C80211BBEF67CCE69 | catalog.json/records/31/monitoring/1 | Historical; current review incomplete |
H51-212644BE82690970ED81B7A9 | catalog.json/records/31/monitoring/2 | Historical; current review incomplete |
H51-50C089A9CF3C139D4678827C | catalog.json/records/31/populations/0 | Historical; current review incomplete |
H51-F12B6FF5615F9F72A71697AB | catalog.json/records/31/evidence_tier | Historical; current review incomplete |
H51-29C9F9580935E08366E11146 | catalog.json/records/31/high_alert | Historical; current review incomplete |
H51-2BB019F31D0ECD4582131F30 | catalog.json/records/31/hazardous | Historical; current review incomplete |
H51-F7B42EDED6D4F454F4502A8A | catalog.json/records/31/status | Historical; current review incomplete |
H51-516788AA09AE8DD29C7D0F24 | catalog.json/records/31/reviewed | Historical; current review incomplete |
H51-6E61FC2C6D3A3807E3261192 | catalog.json/records/31/version_added | Historical; current review incomplete |
H51-E390D847607A5857B606E024 | catalog.json/records/31/sources/0 | Historical; current review incomplete |
H51-7A18326CC37DC2844A0B4B07 | catalog.json/records/31/sources/0/label | Historical; current review incomplete |
H51-774973EADD31B45C4F4E85A1 | catalog.json/records/31/sources/0/url | Historical; current review incomplete |
H51-D97696143882A5FA760680A2 | catalog.json/records/31/sources/0/kind | Historical; current review incomplete |
H51-9EA5813F9E0238FE3435CE52 | catalog.json/records/31/sources/1 | Historical; current review incomplete |
H51-6074F9C3E041D91C9F7ADF95 | catalog.json/records/31/sources/1/label | Historical; current review incomplete |
H51-B9068BD615C754EE7018ACFF | catalog.json/records/31/sources/1/url | Historical; current review incomplete |
H51-D8FFC5D5A93DAF6123D699F7 | catalog.json/records/31/sources/1/kind | Historical; current review incomplete |
H51-14E1653D8053EA84A3792D2C | catalog.json/records/31/legacy_title | Historical; current review incomplete |
H51-4A2D44AC6C87FCB0C43E8732 | catalog.json/records/31/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-FFAD45EFB8E7638656DDF19D | catalog.json/records/31/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-F3EE38C54B4E0DFACF9B4D36 | catalog.json/records/31/clinical_release_verification/level | Historical; current review incomplete |
H51-DE9AADA8B7DF89226CA1F430 | catalog.json/records/31/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-94A9DCC821708518746EAF35 | catalog.json/records/31/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-5EDEE74702FE2DF0DD06BF8C | catalog.json/records/31/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-1EB657654E563471B0549CFE | catalog.json/records/31/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-571C76EBB33B28571CDD667B | catalog.json/records/31/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-0D32C1CC677634EFB295365E | catalog.json/records/31/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-07F312CCEC1A4BAC229AE5C2 | catalog.json/records/31/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-13AC7F70D051A7F835AD6D17 | catalog.json/records/31/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-E4374D159155B8E87876A322 | catalog.json/records/31/clinical_release_verification/note | Historical; current review incomplete |
H51-99A656C751CDF5E35C6B8CC8 | catalog.json/records/31/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-92DF6BFF9D3B1851892D59E7 | dailymed-label-snapshots-v5.1.json/records/7/id | Historical; current review incomplete |
H51-3D9A156AF433F7B5AB6175DA | dailymed-label-snapshots-v5.1.json/records/7/catalog_name | Historical; current review incomplete |
H51-4C806F0657B3CD885EB404CB | dailymed-label-snapshots-v5.1.json/records/7/selection_status | Historical; current review incomplete |
H51-88DFAE9ED170616D58E79345 | dailymed-label-snapshots-v5.1.json/records/7/confidence | Historical; current review incomplete |
H51-1BEC7ACE88CE276E51B81CDA | dailymed-label-snapshots-v5.1.json/records/7/match_path | Historical; current review incomplete |
H51-19C132FE7213289CE6D5AA46 | dailymed-label-snapshots-v5.1.json/records/7/brand_name | Historical; current review incomplete |
H51-9649E08C488A55E334D22326 | dailymed-label-snapshots-v5.1.json/records/7/label_title | Historical; current review incomplete |
H51-577045A03D4516F698F9EA55 | dailymed-label-snapshots-v5.1.json/records/7/setid | Historical; current review incomplete |
H51-055401EDED5B5DBA203BE5AC | dailymed-label-snapshots-v5.1.json/records/7/route | Historical; current review incomplete |
H51-A1B600E36381088FCB2EFE6F | dailymed-label-snapshots-v5.1.json/records/7/dosage_form | Historical; current review incomplete |
H51-B006A4E4EE67E27DE526FBC9 | dailymed-label-snapshots-v5.1.json/records/7/dosage_administration_summary/0 | Historical; current review incomplete |
H51-F31EEC8BA0336DDF90934A17 | dailymed-label-snapshots-v5.1.json/records/7/dosage_administration_summary/1 | Historical; current review incomplete |
H51-DB6060CF7D4D90BAE3EC86AB | dailymed-label-snapshots-v5.1.json/records/7/dosage_administration_summary/2 | Historical; current review incomplete |
H51-63B633075FB00D87B0634D52 | dailymed-label-snapshots-v5.1.json/records/7/dosage_forms_strengths/0 | Historical; current review incomplete |
H51-7459A4B1F5499F4874171C83 | dailymed-label-snapshots-v5.1.json/records/7/mechanism_summary | Historical; current review incomplete |
H51-98DD676F8C95E1F2087F47CF | dailymed-label-snapshots-v5.1.json/records/7/scope_note | Historical; current review incomplete |
H51-64ED819676018E574EBB4004 | dailymed-label-snapshots-v5.1.json/records/7/labeler | Historical; current review incomplete |
H51-51874F9BC9C2752BBC1AFC25 | dailymed-label-snapshots-v5.1.json/records/7/official_label_url | Historical; current review incomplete |
H51-7D59700845DFD4B6D22C1886 | dailymed-label-snapshots-v5.1.json/records/7/reviewed_on | Historical; current review incomplete |
H51-214A4A458BAB8C269DBE18A2 | dailymed-label-snapshots-v5.1.json/records/7/mechanism_source | Historical; current review incomplete |
H51-169EA391AC12A06DE84FFC6C | dailymed-label-snapshots-v5.1.json/records/7/source_sections/0 | Historical; current review incomplete |
H51-84FA63A3AE3F38A138932C81 | dailymed-label-snapshots-v5.1.json/records/7/source_sections/1 | Historical; current review incomplete |
H51-ED1EC425C7CB11818D31CAD6 | dailymed-label-snapshots-v5.1.json/records/7/source_sections/2 | Historical; current review incomplete |
H51-B435C64ECED02E8A56050BBE | dailymed-label-snapshots-v5.1.json/records/7/retrieval_method | Historical; current review incomplete |
H51-00AE73A9ED9DC3C7974CDD5B | dailymed-label-snapshots-v5.1.json/records/7/label_status | Historical; current review incomplete |
H51-94014A4DA36300744EBE55C3 | dailymed-label-snapshots-v5.1.json/records/7/disclaimer | Historical; current review incomplete |
H51-B63AF989A332E2D57A40D61F | dosing.json/records/31/id | Historical; current review incomplete |
H51-86CCCA8BD094C9C4D2B3F7EE | dosing.json/records/31/generic_name | Historical; current review incomplete |
H51-5DF5E1AF02B533108EF9A589 | dosing.json/records/31/coverage_status | Historical; current review incomplete |
H51-403041655876783D932A4131 | dosing.json/records/31/package_insert/query_name | Historical; current review incomplete |
H51-8F650CF0316079746B7B48E4 | dosing.json/records/31/package_insert/preferred_setid | Historical; current review incomplete |
H51-53FAE84B322460614D39093E | dosing.json/records/31/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-1E4E51ADE2C3798CF72C578C | dosing.json/records/31/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-FB91303C4828F34C9795C948 | dosing.json/records/31/package_insert/source_priority | Historical; current review incomplete |
H51-3B2C8B3CDB81E37F8CBECAF2 | dosing.json/records/31/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-B6A106F141570BAF7ECFC9F0 | dosing.json/records/31/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-2C856525FBC7BF5785FB9EE4 | dosing.json/records/31/package_insert/local_summary_status | Historical; current review incomplete |
H51-5B45761FF81BADBA0E6768AD | dosing.json/records/31/renal/classification | Historical; current review incomplete |
H51-101E8067CF14CB16EEAC29DD | dosing.json/records/31/renal/summary | Historical; current review incomplete |
H51-68183DA12EDFB436EEE1BD0E | dosing.json/records/31/renal/method_note | Historical; current review incomplete |
H51-E4FE6BCC1B649F1210F7D895 | dosing.json/records/31/existing_route_snapshots/0 | Historical; current review incomplete |
H51-4A358937FAB394CC1B6459BC | dosing.json/records/31/existing_route_snapshots/0/route | Historical; current review incomplete |
H51-48385FB0B09AC369612DE979 | dosing.json/records/31/existing_route_snapshots/0/population | Historical; current review incomplete |
H51-648E67BE393858C983B7761E | dosing.json/records/31/existing_route_snapshots/0/indication | Historical; current review incomplete |
H51-5431DE31292388B034F76E14 | dosing.json/records/31/existing_route_snapshots/0/dose | Historical; current review incomplete |
H51-CDA7060E4A739B6AD8A794FD | dosing.json/records/31/existing_route_snapshots/0/interval | Historical; current review incomplete |
H51-B48DB1F2F29FC57D640ABC28 | dosing.json/records/31/existing_route_snapshots/0/duration | Historical; current review incomplete |
H51-38643E267A1D93AEBF609FA5 | dosing.json/records/31/existing_route_snapshots/0/administration | Historical; current review incomplete |
H51-A0CCEF6F7BE5889FADC3AC98 | dosing.json/records/31/existing_route_snapshots/0/source_level | Historical; current review incomplete |
H51-84F7DCB3FD7DCDBAD3FAABB7 | dosing.json/records/31/existing_route_snapshots/0/notes | Historical; current review incomplete |
H51-EA477F57B23E5DF9E81D87EC | dosing.json/records/31/existing_route_snapshots/1 | Historical; current review incomplete |
H51-1D435928143AA3BCC5370CB8 | dosing.json/records/31/existing_route_snapshots/1/route | Historical; current review incomplete |
H51-2A8A4AB53970F2AE830F790F | dosing.json/records/31/existing_route_snapshots/1/population | Historical; current review incomplete |
H51-42BD3628B4B9882415F5C80F | dosing.json/records/31/existing_route_snapshots/1/indication | Historical; current review incomplete |
H51-83B8621FC69CEEE045CDE5E5 | dosing.json/records/31/existing_route_snapshots/1/dose | Historical; current review incomplete |
H51-06AD6F2E8E202482789D2624 | dosing.json/records/31/existing_route_snapshots/1/interval | Historical; current review incomplete |
H51-A62F2A9D0CB9F55195F33C4A | dosing.json/records/31/existing_route_snapshots/1/duration | Historical; current review incomplete |
H51-FE69DA9227DB880BC4DD3CE9 | dosing.json/records/31/existing_route_snapshots/1/administration | Historical; current review incomplete |
H51-BACA9245ADA283B4364EE538 | dosing.json/records/31/existing_route_snapshots/1/source_level | Historical; current review incomplete |
H51-A009D1B5C6167282DDAC46F3 | dosing.json/records/31/existing_route_snapshots/1/notes | Historical; current review incomplete |
H51-F18AB587EBF9A0A7B6B877FC | dosing.json/records/31/professional_sources/0 | Historical; current review incomplete |
H51-97F4F7C000A1C5B49934BA32 | dosing.json/records/31/professional_sources/0/label | Historical; current review incomplete |
H51-89554F5190284F37FA307A3C | dosing.json/records/31/professional_sources/0/url | Historical; current review incomplete |
H51-483686669521775532CBD223 | dosing.json/records/31/professional_sources/0/kind | Historical; current review incomplete |
H51-ECC625F5C52FC66825785F7B | dosing.json/records/31/professional_sources/1 | Historical; current review incomplete |
H51-215A975FABE8A5804029BA7C | dosing.json/records/31/professional_sources/1/label | Historical; current review incomplete |
H51-7BB3BD370CC12FCDF6E9A5B6 | dosing.json/records/31/professional_sources/1/url | Historical; current review incomplete |
H51-BDE405F25E19BB2DA5049F04 | dosing.json/records/31/professional_sources/1/kind | Historical; current review incomplete |
H51-6EBA7DEA1A8ABDD97E368EA6 | dosing.json/records/31/professional_sources/2 | Historical; current review incomplete |
H51-ADDF409C5E4E1B714583E004 | dosing.json/records/31/professional_sources/2/label | Historical; current review incomplete |
H51-7B7590B227E5C242026660AE | dosing.json/records/31/professional_sources/2/url | Historical; current review incomplete |
H51-B4DC3B4B3ECDD7D22E8D9A43 | dosing.json/records/31/professional_sources/2/kind | Historical; current review incomplete |
H51-B26800CE76E9DCEE5D452D1D | dosing.json/records/31/professional_sources/3 | Historical; current review incomplete |
H51-E0392A75B2E1BA5F83AED7EC | dosing.json/records/31/professional_sources/3/label | Historical; current review incomplete |
H51-BFD0A8D7B7A5A272E0DB355C | dosing.json/records/31/professional_sources/3/url | Historical; current review incomplete |
H51-E711866553C267FE26F9429B | dosing.json/records/31/professional_sources/3/kind | Historical; current review incomplete |
H51-45C7E90FFA7DEAA87D18F1C0 | dosing.json/records/31/clinical_review/locally_normalized | Historical; current review incomplete |
H51-86BA40EF81AD390F49571275 | dosing.json/records/31/clinical_review/reviewed | Historical; current review incomplete |
H51-5BA1BA02D354789CF3469B85 | dosing.json/records/31/clinical_review/status | Historical; current review incomplete |
H51-51E07DA5D1B2F771A089EDA3 | dosing.json/records/31/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-DC045BC6D2B17DA7818B9AFA | dosing.json/records/31/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-CA77BFA6168E048C918984B5 | dosing.json/records/31/clinical_release_verification/level | Historical; current review incomplete |
H51-1EB5BFEDEAE0FA3D09E5AD77 | dosing.json/records/31/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-C36644D0553C0C4FEBAFF797 | dosing.json/records/31/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-6E45BEDF98B64205C17585DF | dosing.json/records/31/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-5E6CBD21F0F8AE4F9A5FF3A1 | dosing.json/records/31/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-36F015F073D3147EEA2F4B2D | dosing.json/records/31/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-9339434522490A28FE5C438F | dosing.json/records/31/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-02F777E3DFF89942E3D8E2DF | dosing.json/records/31/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-6E450DE9B6EE9CFBDC59E71C | dosing.json/records/31/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-C96F9956D5BBCDB64A5093AD | dosing.json/records/31/clinical_release_verification/note | Historical; current review incomplete |
H51-D12F3EDAF47CBE79D2ADDDD8 | dosing.json/records/31/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-A5A01B76C6D9AB1DB1C145AB | first-look-v5.1.json/records/31/id | Historical; current review incomplete |
H51-91BA4C704E7F2E2D638E0A86 | first-look-v5.1.json/records/31/generic_name | Historical; current review incomplete |
H51-32F3B671D5650E9B2DEFE71A | first-look-v5.1.json/records/31/class | Historical; current review incomplete |
H51-2E06C58EA372AEC9A36526AD | first-look-v5.1.json/records/31/subclass | Historical; current review incomplete |
H51-DF1EA00DAD62BDEDF49CB2E3 | first-look-v5.1.json/records/31/primary_uses/0 | Historical; current review incomplete |
H51-8FD20D26D30DB28D9A66FF3F | first-look-v5.1.json/records/31/mechanism | Historical; current review incomplete |
H51-9A31ECB8CB5C33699965C6D5 | first-look-v5.1.json/records/31/mechanism_level | Historical; current review incomplete |
H51-23D5BCC3224D0DD731BA5BB6 | first-look-v5.1.json/records/31/basic_dosing_orientation | Historical; current review incomplete |
H51-230E2ACD75EAF7EDFA60FED8 | first-look-v5.1.json/records/31/administration_orientation | Historical; current review incomplete |
H51-5BF7244B7FF95BA415C0BECD | first-look-v5.1.json/records/31/renal_and_population_orientation | Historical; current review incomplete |
H51-48AE9DA8D108BBD72BFEA727 | first-look-v5.1.json/records/31/key_safety_orientation/0 | Historical; current review incomplete |
H51-908E7E87694D4E9462140587 | first-look-v5.1.json/records/31/key_safety_orientation/1 | Historical; current review incomplete |
H51-397FC552BB53070847E2915D | first-look-v5.1.json/records/31/key_safety_orientation/2 | Historical; current review incomplete |
H51-D681336243C5F5A275752B76 | first-look-v5.1.json/records/31/coverage_path | Historical; current review incomplete |
H51-22FD6D8F86D820EE5872571D | first-look-v5.1.json/records/31/coverage_path_label | Historical; current review incomplete |
H51-4CFD828A6E1C307762A8EB7A | first-look-v5.1.json/records/31/official_label_url | Historical; current review incomplete |
H51-7DD117D20521EDCE8F598CE1 | first-look-v5.1.json/records/31/legacy_title | Historical; current review incomplete |
H51-75E6FB5D8B7B505CB9F386C2 | first-look-v5.1.json/records/31/review_note | Historical; current review incomplete |
H51-23F831DEC92B7F5FDA3B9280 | first-look-v5.1.json/records/31/search_text | Historical; current review incomplete |
H51-4267487846D67A031AAD7A37 | first-look-v5.1.json/records/31/official_search_url | Historical; current review incomplete |
H51-F14024DD4F7F8CDA9A0D73B2 | first-look-v5.1.json/records/31/official_access_mode | Historical; current review incomplete |
H51-1151DAF92398782E5F5CB929 | first-look-v5.1.json/records/31/official_access_url | Historical; current review incomplete |
H51-3DD6D79AD15A35F58907FC68 | first-look-v5.1.json/records/31/official_search_query | Historical; current review incomplete |
H51-D23643CC0F870838D6EF83BD | first-look-v5.1.json/records/31/official_access_reason | Historical; current review incomplete |
H51-03B9EE4C9B46A0B167F7323A | first-look-v5.1.json/records/31/label_snapshot_available | Historical; current review incomplete |
H51-B53A1E200C4CB593405267F5 | first-look-v5.1.json/records/31/label_snapshot_setid | Historical; current review incomplete |
H51-DA6B6D49ACF3A53AFEB4C07F | preparation-assessments-v3.8.json/31/id | Historical; current review incomplete |
H51-29059C8850426CE5C71D223C | preparation-assessments-v3.8.json/31/name | Historical; current review incomplete |
H51-2364EE1777C9D4B3D073370B | preparation-assessments-v3.8.json/31/brands | Historical; current review incomplete |
H51-D806F1896C6BDE6FC906D4DC | preparation-assessments-v3.8.json/31/therapeutic_class | Historical; current review incomplete |
H51-82E5C493CAB51F32F0120322 | preparation-assessments-v3.8.json/31/review_version | Historical; current review incomplete |
H51-F0C0BDD079D88AE4A8788CA1 | preparation-assessments-v3.8.json/31/review_date | Historical; current review incomplete |
H51-195C978414E01D5025334D12 | preparation-assessments-v3.8.json/31/release_status | Historical; current review incomplete |
H51-15CAEA345C46768BD89BC03C | preparation-assessments-v3.8.json/31/market_status/status | Historical; current review incomplete |
H51-8D4BAE73DC380B9607A390EB | preparation-assessments-v3.8.json/31/market_status/basis | Historical; current review incomplete |
H51-48BC0ACA5B37726E23081432 | preparation-assessments-v3.8.json/31/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-8E3831FA3FF3B32D5AB5D41D | preparation-assessments-v3.8.json/31/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-6BC6ACBBACF285BD0FE8C127 | preparation-assessments-v3.8.json/31/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-4974148E7AC6F7AD6000DD7A | preparation-assessments-v3.8.json/31/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-3EC996A273B4053F34795CA7 | preparation-assessments-v3.8.json/31/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-08EE8A45C6DDCD888FA125AB | preparation-assessments-v3.8.json/31/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-1974D02F6987DA83504D0081 | preparation-assessments-v3.8.json/31/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-4A55BC0CCF1E16E45655C175 | preparation-assessments-v3.8.json/31/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-1F67E799A779F269D5806B12 | preparation-assessments-v3.8.json/31/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-751ABA453954D76C0D80713C | preparation-assessments-v3.8.json/31/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-2E6519916CEDC4251249534D | preparation-assessments-v3.8.json/31/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-8CD60C2FFDDF47FFF1841074 | preparation-assessments-v3.8.json/31/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-D21CB055ACDE9B8F93A8B815 | preparation-assessments-v3.8.json/31/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-81AA99104FAA9D56C23C89B1 | preparation-assessments-v3.8.json/31/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-915C2C377C9EB3A6ECC621BC | preparation-assessments-v3.8.json/31/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-CED7E69D02780598769CC189 | preparation-assessments-v3.8.json/31/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-0AC4B622FE14DCAAB7419924 | preparation-assessments-v3.8.json/31/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-F06DE5159B46A03A9FB9BEEA | preparation-assessments-v3.8.json/31/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-DB0E037E8FF966716FAB44A4 | preparation-assessments-v3.8.json/31/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-7BB16751FF1180AB059C0D1A | preparation-assessments-v3.8.json/31/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-A058A11DC4B1C4D64C041D6E | preparation-assessments-v3.8.json/31/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-35FD67E3EDF1CAD3156D3EB1 | preparation-assessments-v3.8.json/31/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-F0343470C87CE484367B0DD4 | preparation-assessments-v3.8.json/31/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-6B642D510D3021CA20A29A79 | preparation-assessments-v3.8.json/31/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-B8278620FD238614E2CFF71B | preparation-assessments-v3.8.json/31/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-3BFB82D1F2AFDD341C6F0DDA | preparation-assessments-v3.8.json/31/population_applicability/adult/applicability | Historical; current review incomplete |
H51-8EA8A7676CBB35AB34336856 | preparation-assessments-v3.8.json/31/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-01E08233A526D4520EC4C377 | preparation-assessments-v3.8.json/31/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-93E24CCA3751E62A6E954A30 | preparation-assessments-v3.8.json/31/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-C76F2D0FB74AF05A0C8FC6C8 | preparation-assessments-v3.8.json/31/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-5D412E91E605E8581DCFF36A | preparation-assessments-v3.8.json/31/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-9F283B05AE30598B453B4A75 | preparation-assessments-v3.8.json/31/route_presence/structured_dilution | Historical; current review incomplete |
H51-E49A5EF7593841698DE38128 | preparation-assessments-v3.8.json/31/route_presence/iv_push | Historical; current review incomplete |
H51-8892B22256F155C9CBD73917 | preparation-assessments-v3.8.json/31/route_presence/continuous_infusion | Historical; current review incomplete |
H51-657EB1F29D912CADD89916BB | preparation-assessments-v3.8.json/31/route_presence/pediatric_source | Historical; current review incomplete |
H51-81DAEB99F6A5E5D17A5EC1AA | preparation-assessments-v3.8.json/31/route_presence/neonatal_source | Historical; current review incomplete |
H51-668B28DF690090F4099B3A9B | preparation-assessments-v3.8.json/31/legacy_reference/status | Historical; current review incomplete |
H51-A3760A7A9DB5FB90DB3F774E | preparation-assessments-v3.8.json/31/label_resolution/status | Historical; current review incomplete |
H51-17597A3AE0C8A4DE78A898D2 | preparation-assessments-v3.8.json/31/label_resolution/existing_setids/0 | Historical; current review incomplete |
H51-3F21567D1A964BCD744E6631 | preparation-assessments-v3.8.json/31/source_files/0 | Historical; current review incomplete |
H51-C9D7E8EFAD7F140BBADD8082 | preparation-assessments-v3.8.json/31/source_files/1 | Historical; current review incomplete |
H51-CAE4CF033DBCEF10E6F2E69F | preparation-assessments-v3.8.json/31/source_files/2 | Historical; current review incomplete |
H51-9BA7C7CF8590FB55164A90B1 | preparation-assessments-v3.8.json/31/clinical_release_note | Historical; current review incomplete |